LCG
EVH icon

Lisanti Capital Growth’s Evolent Health EVH Stock Holding History

Lisanti Capital Growth’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-52,060
Closed -$1.71M – 121
2024
Q1 		$1.71M Sell
52,060
-2,130
-4% -$68K 0.42% 83
2023
Q4 		$1.79M Buy
+54,190
New +$1.53M 0.42% 87
2023
Q2 		– Sell
-319,560
Closed -$10.4M – 149
2023
Q1 		$10.4M Buy
+319,560
New +$10.1M 1.45% 21
2022
Q4 		– Sell
-221,380
Closed -$7.95M – 137
2022
Q3 		$7.95M Sell
221,380
-58,035
-21% -$2.04M 1.06% 34
2022
Q2 		$8.58M Buy
+279,415
New +$8.14M 1.17% 32

Other funds holding EVH

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
RSCM
Rock Springs Capital Management Baltimore, Maryland $1.7B AUM 93.03% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return

Lisanti Capital Growth's EVH Position: Q2 2024 in Review

Lisanti Capital Growth sold out of Evolent Health (EVH) in Q2 2024, closing a stake of 52,060 shares — an estimated $1.71M sold.

Lisanti Capital Growth first reported a position in EVH in Q2 2022 and held it in 5 quarters. The position peaked at $10.4M in Q1 2023. 243 funds tracked by Wall St. Rank hold EVH as of Q2 2024.

  • Lisanti Capital Growth reported no remaining Evolent Health position as of Q2 2024 after selling out during the quarter.
  • Lisanti Capital Growth sold 52,060 Evolent Health shares in Q2 2024, an estimated $1.71M.
  • Lisanti Capital Growth first reported a position in Evolent Health in Q2 2022 and held it in 5 quarters.
  • Lisanti Capital Growth's Evolent Health position peaked at $10.4M in Q1 2023.
  • 243 funds tracked by Wall St. Rank held Evolent Health as of Q2 2024.

Based on Lisanti Capital Growth's 13F filing for Q2 2024, filed 1 Aug 2024.